{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:54:53Z","timestamp":1788317693421,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,19]]},"DOI":"10.7759\/cureus.29344","type":"journal-article","created":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T04:00:43Z","timestamp":1663646443000},"source":"Crossref","is-referenced-by-count":3,"title":["The Refinement of Home Exercise Program for Children and Adolescents With Muscular Dystrophy in the Present COVID-19 Pandemic Scenario: A Scoping Review"],"prefix":"10.7759","author":[{"given":"Pallavi","family":"Harjpal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh K","family":"Kovela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anushka","family":"Raipure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charul","family":"Dandale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moh'd Irshad","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32910-1","article-title":"Muscular dystrophies","volume":"394","author":"Mercuri E","year":"2019","unstructured":"Mercuri E, B\u00f6nnemann CG, Muntoni F. Muscular dystrophies. Lancet Lond Engl. 2019, 394:2025-38. 10.1016\/S0140-6736(19)32910-1","journal-title":"Lancet Lond Engl"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuro.2016.03.007","article-title":"A systematic review of risk factors associated with muscular dystrophies","volume":"61","author":"Barakat-Haddad C","year":"2017","unstructured":"Barakat-Haddad C, Shin S, Candundo H, Lieshout PV, Martino R. A systematic review of risk factors associated with muscular dystrophies. Neurotoxicology. 2017, 61:55-62. 10.1016\/j.neuro.2016.03.007","journal-title":"Neurotoxicology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2013.04.004","article-title":"Muscular dystrophies and other genetic myopathies","volume":"31","author":"Shieh PB","year":"2013","unstructured":"Shieh PB. Muscular dystrophies and other genetic myopathies. Neurol Clin. 2013, 31:1009-29. 10.1016\/j.ncl.2013.04.004","journal-title":"Neurol Clin"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/456348","article-title":"Muscular dystrophy: disease mechanisms and therapies","volume":"2015","author":"Pandey SN","year":"2015","unstructured":"Pandey SN, Kesari A, Yokota T, Pandey GS. Muscular dystrophy: disease mechanisms and therapies. Biomed Res Int. 2015, 2015:456348. 10.1155\/2015\/456348","journal-title":"Biomed Res Int"},{"key":"ref5","article-title":"Duchenne muscular dystrophy","author":"Venugopal V","year":"2022","unstructured":"Venugopal V, Pavlakis S. Duchenne muscular dystrophy. StatPearls Publishing, Treasure Island, FL; 2022."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.gaitpost.2008.06.002","article-title":"Gait pattern in Duchenne muscular dystrophy","volume":"29","author":"D'Angelo MG","year":"2009","unstructured":"D'Angelo MG, Berti M, Piccinini L, et al.. Gait pattern in Duchenne muscular dystrophy. Gait Posture. 2009, 29:36-41. 10.1016\/j.gaitpost.2008.06.002","journal-title":"Gait Posture"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32160-8","article-title":"Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study","volume":"391","author":"McDonald CM","year":"2018","unstructured":"McDonald CM, Henricson EK, Abresch RT, et al.. Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study. Lancet Lond Engl. 2018, 391:451-61. 10.1016\/S0140-6736(17)32160-8","journal-title":"Lancet Lond Engl"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2018.01.004","article-title":"Muscular dystrophies","volume":"39","author":"Carter JC","year":"2018","unstructured":"Carter JC, Sheehan DW, Prochoroff A, Birnkrant DJ. Muscular dystrophies. Clin Chest Med. 2018, 39:377-89. 10.1016\/j.ccm.2018.01.004","journal-title":"Clin Chest Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2014.200","article-title":"A phase 1\/2a follistatin gene therapy trial for becker muscular dystrophy","volume":"23","author":"Mendell JR","year":"2015","unstructured":"Mendell JR, Sahenk Z, Malik V, et al.. A phase 1\/2a follistatin gene therapy trial for becker muscular dystrophy. Mol Ther. 2015, 23:192-201. 10.1038\/mt.2014.200","journal-title":"Mol Ther"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1212\/CON.0000000000000399","article-title":"Facioscapulohumeral muscular dystrophy","volume":"22","author":"Statland JM","year":"2016","unstructured":"Statland JM, Tawil R. Facioscapulohumeral muscular dystrophy. Continuum (Minneap Minn). 2016, 22:1916-31. 10.1212\/CON.0000000000000399","journal-title":"Continuum (Minneap Minn)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s13052-016-0289-9","article-title":"Congenital muscular dystrophy: from muscle to brain","volume":"42","author":"Falsaperla R","year":"2016","unstructured":"Falsaperla R, Pratic\u00f2 AD, Ruggieri M, et al.. Congenital muscular dystrophy: from muscle to brain. Ital J Pediatr. 2016, 42:78. 10.1186\/s13052-016-0289-9","journal-title":"Ital J Pediatr"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s12098-017-2397-y","article-title":"Duchenne muscular dystrophy: a practice update","volume":"85","author":"Suthar R","year":"2018","unstructured":"Suthar R, Sankhyan N. Duchenne muscular dystrophy: a practice update. Indian J Pediatr. 2018, 85:276-81. 10.1007\/s12098-017-2397-y","journal-title":"Indian J Pediatr"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2223\/JPED.2148","article-title":"Mental retardation in Duchenne muscular dystrophy","volume":"88","author":"Nardes F","year":"2012","unstructured":"Nardes F, Ara\u00fajo AP, Ribeiro MG. Mental retardation in Duchenne muscular dystrophy. J Pediatr (Rio J). 2012, 88:6-16. 10.2223\/JPED.2148","journal-title":"J Pediatr (Rio J)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2302\/kjm.58.223","article-title":"Activities of daily living (ADL) structure of patients with Duchenne muscular dystrophy, including adults","volume":"58","author":"Fujiwara T","year":"2009","unstructured":"Fujiwara T, Tanabe A, Uchikawa K, Tsuji T, Tanuma A, Hase K, Liu M. Activities of daily living (ADL) structure of patients with Duchenne muscular dystrophy, including adults. Keio J Med. 2009, 58:223-6. 10.2302\/kjm.58.223","journal-title":"Keio J Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8749.2007.00846.x","article-title":"Use of the Bruininks-Oseretsky Test of Motor Proficiency for identifying children with motor impairment","volume":"49","author":"Venetsanou F","year":"2007","unstructured":"Venetsanou F, Kambas A, Aggeloussis N, Serbezis V, Taxildaris K. Use of the Bruininks-Oseretsky Test of Motor Proficiency for identifying children with motor impairment. Dev Med Child Neurol. 2007, 49:846-8. 10.1111\/j.1469-8749.2007.00846.x","journal-title":"Dev Med Child Neurol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1080\/08990220.2020.1784131","article-title":"Comparison of motor proficiency and functional ambulation in Duchenne muscular dystrophy with healthy peers","volume":"37","author":"Yildiz S","year":"2020","unstructured":"Yildiz S, Sahin S, Bulut N, Tunca Yilmaz O, Karaduman AA, Akel BS. Comparison of motor proficiency and functional ambulation in Duchenne muscular dystrophy with healthy peers. Somatosens Mot Res. 2020, 37:252-6. 10.1080\/08990220.2020.1784131","journal-title":"Somatosens Mot Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-018-3555-3","article-title":"Clinical management of Duchenne muscular dystrophy: the state of the art","volume":"39","author":"Messina S","year":"2018","unstructured":"Messina S, Vita GL. Clinical management of Duchenne muscular dystrophy: the state of the art. Neurol Sci. 2018, 39:1837-45. 10.1007\/s10072-018-3555-3","journal-title":"Neurol Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s00508-020-01786-8","article-title":"Establishing a\u00a0telerehabilitation program for patients with Duchenne muscular dystrophy in the COVID-19 pandemic","volume":"133","author":"Sobierajska-Rek A","year":"2021","unstructured":"Sobierajska-Rek A, Ma\u0144ski \u0141, Jab\u0142o\u0144ska-Brud\u0142o J, \u015aledzi\u0144ska K, Uci\u0144ska A, Wierzba J. Establishing a\u00a0telerehabilitation program for patients with Duchenne muscular dystrophy in the COVID-19 pandemic. Wien Klin Wochenschr. 2021, 133:344-50. 10.1007\/s00508-020-01786-8","journal-title":"Wien Klin Wochenschr"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30025-5","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management","volume":"17","author":"Birnkrant DJ","year":"2018","unstructured":"Birnkrant DJ, Bushby K, Bann CM, et al.. Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management. Lancet Neurol. 2018, 17:347-61. 10.1016\/S1474-4422(18)30025-5","journal-title":"Lancet Neurol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/mus.26902","article-title":"The care of patients with Duchenne, Becker, and other muscular dystrophies in the COVID-19 pandemic","volume":"62","author":"Veerapandiyan A","year":"2020","unstructured":"Veerapandiyan A, Wagner KR, Apkon S, et al.. The care of patients with Duchenne, Becker, and other muscular dystrophies in the COVID-19 pandemic. Muscle Nerve. 2020, 62:41-5. 10.1002\/mus.26902","journal-title":"Muscle Nerve"},{"key":"ref21","unstructured":"Report of the WCPT\/INPTRA Digital Physical Therapy Practice Task Force. (2020). https.\/\/world.physio\/sites\/default\/files\/2020-06\/WCPT-INPTRA-Digital-Physical-Therapy-Practice-Task-force-March2020.pdf."},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1097\/MOP.0b013e328365ace5","article-title":"Muscular dystrophy: new challenges and review of the current clinical trials","volume":"25","author":"Mercuri E","year":"2013","unstructured":"Mercuri E, Muntoni F. Muscular dystrophy: new challenges and review of the current clinical trials. Curr Opin Pediatr. 2013, 25:701-7. 10.1097\/MOP.0b013e328365ace5","journal-title":"Curr Opin Pediatr"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30024-3","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management","volume":"17","author":"Birnkrant DJ","year":"2018","unstructured":"Birnkrant DJ, Bushby K, Bann CM, et al.. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurol. 2018, 17:251-67. 10.1016\/S1474-4422(18)30024-3","journal-title":"Lancet Neurol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for Scoping Reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco AC","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, et al.. PRISMA extension for Scoping Reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018, 169:467-73. 10.7326\/M18-0850","journal-title":"Ann Intern Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-13-48","article-title":"Enhancing the scoping study methodology: a large, inter-professional team's experience with Arksey and O'Malley's framework","volume":"13","author":"Daudt HM","year":"2013","unstructured":"Daudt HM, van Mossel C, Scott SJ. Enhancing the scoping study methodology: a large, inter-professional team's experience with Arksey and O'Malley's framework. BMC Med Res Methodol. 2013, 13:48. 10.1186\/1471-2288-13-48","journal-title":"BMC Med Res Methodol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1097\/XEB.0000000000000050","article-title":"Guidance for conducting systematic scoping reviews","volume":"13","author":"Peters MD","year":"2015","unstructured":"Peters MD, Godfrey CM, Khalil H, McInerney P, Parker D, Soares CB. Guidance for conducting systematic scoping reviews. Int J Evid Based Healthc. 2015, 13:141-6. 10.1097\/XEB.0000000000000050","journal-title":"Int J Evid Based Healthc"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18126179","article-title":"Respiratory telerehabilitation of boys and young men with Duchenne muscular dystrophy in the COVID-19 pandemic","volume":"18","author":"Sobierajska-Rek A","year":"2021","unstructured":"Sobierajska-Rek A, Ma\u0144ski \u0141, Jab\u0142o\u0144ska-Brud\u0142o J, \u015aledzi\u0144ska K, Wasilewska E, Szalewska D. Respiratory telerehabilitation of boys and young men with Duchenne muscular dystrophy in the COVID-19 pandemic. Int J Environ Res Public Health. 2021, 18:6179. 10.3390\/ijerph18126179","journal-title":"Int J Environ Res Public Health"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1080\/00913847.2019.1684810","article-title":"Motor activity and Becker\u2019s muscular dystrophy: lights and shadows","volume":"48","author":"Lanza G","year":"2020","unstructured":"Lanza G, Pino M, Fisicaro F, et al.. Motor activity and Becker\u2019s muscular dystrophy: lights and shadows. Phys Sportsmed. 2020, 48:151-60. 10.1080\/00913847.2019.1684810","journal-title":"Phys Sportsmed"},{"key":"ref29","article-title":"Current and emerging therapies in Becker muscular dystrophy (BMD)","volume":"38","author":"Angelini C","year":"2019","unstructured":"Angelini C, Marozzo R, Pegoraro V. Current and emerging therapies in Becker muscular dystrophy (BMD). Acta Myol. 2019, 38:172-9.","journal-title":"Acta Myol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.37506\/ijphrd.v11i6.9813","article-title":"Effectiveness of Mother as a Rehabilitative Aid (Mara) program in the recovery of children with cerebral palsy-an assessor blinded randomized controlled trial","volume":"11","author":"Jayashree KR","year":"2020","unstructured":"Jayashree KR, Kovela RK, Thakur A, Pamidigantam PR. Effectiveness of Mother as a Rehabilitative Aid (Mara) program in the recovery of children with cerebral palsy-an assessor blinded randomized controlled trial. Indian J Public Health Res Dev. 2020, 11:419-24. 10.37506\/ijphrd.v11i6.9813","journal-title":"Indian J Public Health Res Dev"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/113545-the-refinement-of-home-exercise-program-for-children-and-adolescents-with-muscular-dystrophy-in-the-present-covid-19-pandemic-scenario-a-scoping-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:38:28Z","timestamp":1707507508000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/113545-the-refinement-of-home-exercise-program-for-children-and-adolescents-with-muscular-dystrophy-in-the-present-covid-19-pandemic-scenario-a-scoping-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,19]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.29344","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,19]]}}}